Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE: 300702)
China
· Delayed Price · Currency is CNY 16.40
-0.26 (-1.56%)
Jan 2, 2025, 3:04 PM CST
Zhejiang Tianyu Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,588 | 2,521 | 2,651 | 2,529 | 2,586 | 2,110 | Upgrade
|
| Other Revenue | 6.74 | 6.74 | 15.33 | 16.49 | 1.37 | 0.82 | Upgrade
|
| Revenue | 2,595 | 2,527 | 2,667 | 2,545 | 2,587 | 2,111 | Upgrade
|
| Revenue Growth (YoY) | 6.02% | -5.23% | 4.78% | -1.64% | 22.59% | 43.88% | Upgrade
|
| Cost of Revenue | 1,748 | 1,677 | 2,076 | 1,638 | 1,297 | 976.76 | Upgrade
|
| Gross Profit | 846.19 | 849.83 | 591.07 | 907.42 | 1,290 | 1,134 | Upgrade
|
| Selling, General & Admin | 477.02 | 425.45 | 423.79 | 465.02 | 361.41 | 322.68 | Upgrade
|
| Research & Development | 243.09 | 243.82 | 231.1 | 227.4 | 179.07 | 112.25 | Upgrade
|
| Other Operating Expenses | 33.36 | 28.42 | 19.72 | 24.14 | 26.16 | 21.95 | Upgrade
|
| Operating Expenses | 753.43 | 703.99 | 670.74 | 721.58 | 571.01 | 457.36 | Upgrade
|
| Operating Income | 92.77 | 145.84 | -79.67 | 185.84 | 719.41 | 676.48 | Upgrade
|
| Interest Expense | -55.55 | -49.91 | -33.85 | -16.33 | -4.41 | -12.19 | Upgrade
|
| Interest & Investment Income | 17.24 | 6.07 | 7.22 | 75.73 | 29.84 | 3.21 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.83 | 8.83 | 37.92 | -10.58 | -36.24 | 5.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.69 | -1.33 | -1.28 | -1.12 | -1.18 | -0.6 | Upgrade
|
| EBT Excluding Unusual Items | 62.6 | 109.5 | -69.66 | 233.55 | 707.42 | 672.17 | Upgrade
|
| Gain (Loss) on Sale of Investments | -6.1 | -62.69 | -59.65 | -12.97 | 42.64 | 1.28 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | -0.03 | -0.02 | 0.06 | 0.21 | -0.65 | Upgrade
|
| Asset Writedown | -2.09 | -2.09 | -8.21 | -16.09 | -5.51 | -3.38 | Upgrade
|
| Other Unusual Items | 27.11 | 26.92 | 26.76 | 13.85 | 24.13 | 14.63 | Upgrade
|
| Pretax Income | 81.79 | 71.92 | -110.5 | 218.41 | 768.88 | 684.1 | Upgrade
|
| Income Tax Expense | 38.11 | 44.56 | 8.37 | 13.73 | 101.82 | 98.38 | Upgrade
|
| Net Income | 43.68 | 27.36 | -118.87 | 204.68 | 667.06 | 585.73 | Upgrade
|
| Net Income to Common | 43.68 | 27.36 | -118.87 | 204.68 | 667.06 | 585.73 | Upgrade
|
| Net Income Growth | - | - | - | -69.32% | 13.89% | 257.89% | Upgrade
|
| Shares Outstanding (Basic) | 350 | 342 | 350 | 347 | 324 | 323 | Upgrade
|
| Shares Outstanding (Diluted) | 350 | 342 | 350 | 347 | 325 | 327 | Upgrade
|
| Shares Change (YoY) | 1.95% | -2.18% | 0.78% | 6.61% | -0.62% | 1.15% | Upgrade
|
| EPS (Basic) | 0.12 | 0.08 | -0.34 | 0.59 | 2.06 | 1.81 | Upgrade
|
| EPS (Diluted) | 0.12 | 0.08 | -0.34 | 0.59 | 2.05 | 1.79 | Upgrade
|
| EPS Growth | - | - | - | -71.22% | 14.60% | 253.82% | Upgrade
|
| Free Cash Flow | 238.62 | -360.71 | -575.71 | -998.62 | 116.13 | 73.73 | Upgrade
|
| Free Cash Flow Per Share | 0.68 | -1.05 | -1.65 | -2.88 | 0.36 | 0.23 | Upgrade
|
| Dividend Per Share | 0.050 | 0.050 | - | 0.100 | 0.278 | 0.278 | Upgrade
|
| Dividend Growth | - | - | - | -64.00% | 0% | 233.49% | Upgrade
|
| Gross Margin | 32.61% | 33.63% | 22.17% | 35.65% | 49.87% | 53.72% | Upgrade
|
| Operating Margin | 3.58% | 5.77% | -2.99% | 7.30% | 27.80% | 32.05% | Upgrade
|
| Profit Margin | 1.68% | 1.08% | -4.46% | 8.04% | 25.78% | 27.75% | Upgrade
|
| Free Cash Flow Margin | 9.20% | -14.27% | -21.59% | -39.24% | 4.49% | 3.49% | Upgrade
|
| EBITDA | 422.24 | 438.78 | 164.56 | 371.04 | 855.5 | 777.66 | Upgrade
|
| EBITDA Margin | 16.27% | 17.36% | 6.17% | 14.58% | 33.06% | 36.85% | Upgrade
|
| D&A For EBITDA | 329.48 | 292.94 | 244.23 | 185.2 | 136.1 | 101.18 | Upgrade
|
| EBIT | 92.77 | 145.84 | -79.67 | 185.84 | 719.41 | 676.48 | Upgrade
|
| EBIT Margin | 3.58% | 5.77% | -2.99% | 7.30% | 27.80% | 32.05% | Upgrade
|
| Effective Tax Rate | 46.60% | 61.96% | - | 6.29% | 13.24% | 14.38% | Upgrade
|
| Revenue as Reported | 2,595 | 2,527 | 2,667 | 2,545 | 2,587 | 2,111 | Upgrade
|
| Advertising Expenses | - | 67.59 | 12.92 | 0.97 | 0.87 | 2.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.